2 completed, 1 unknown, 1 withdrawn. 4 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 2, Unknown 1, Withdrawn 1 |
Follow Celtic Pharma Development Services: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| TDT 067 Onychomycosis Study TDT067, Placebo, Transfersome - Onychomycosis | Phase 3 | Unknown | Celtic Pharma Development Services | 738 | 2010-04-01 | 2012-08-01 |
| XERECEPT® (hCRF) for Primary Glioma Patients Requiring Dexamethasone to Treat Peritumoral Brain Edema hCRF, placebo hCRF - Brain Edema, Brain Tumor | Phase 3 | Withdrawn | Celtic Pharma Development Services | 120 | 2006-01-01 | 2008-01-03 |
| An Open-Labeled, Extended-Use of XERECEPT (hCRF) for Patients in Studies NTI 0302, 0303, or Other Designated Studies hCRF [XERECEPT (corticorelin acetate injection)] - Brain Edema, Brain Tumor | Phase 3 | Completed | Celtic Pharma Development Services | 112 | 2005-07-01 | 2012-08-31 |
| XERECEPT® (hCRF) for Patients Requiring Dexamethasone to Treat Edema Associated With Brain Tumors hCRF, placebo hCRF - Brain Edema, Brain Tumor | Phase 3 | Completed | Celtic Pharma Development Services | 200 | 2004-05-01 | 2014-08-13 |
Astrocytoma (3) · Brain Edema (3) · Brain Neoplasms (3) · Edema (3) · Onychomycosis (1)
Corticotropin-Releasing Hormone (3) · Terbinafine (1)
United States (4) · Canada (3)
William Shapiro, MD (3) · Eduardo Tschen, MD (1)